Cassiopea Hair Loss Formulation Patent Refusal Set Aside for Fresh Examination
Cassiopea’s proposed treatment for androgenetic alopecia uses a high concentration of cortexolone-17-α-propionate dissolved in a topical formulation with specified solvents and additives. The Controller rejected its patent application on novelty, inventive step and mere admixture grounds, but did not explain…













